Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer
Completed
Conditions studied: Thyroid Cancer
In brief
This study is being done to understand the decision-making process regarding management choice in low-risk papillary thyroid cancer.
Key facts
- Study ID
- NCT03300284
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 186
- Starts
- 2017-08-07
- Expected to finish
- 2023-07-13
- Last updated by the study team
- 2023-07-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Able to read, write, and communicate in English Patients who have been diagnosed with LR-PTC as described above
- For Aim 1, adults with recently diagnosed LR-PTC who have not yet made a choice between surgery and AS
- For Aim 2, adults with LR-PTC who made a decision about surgery or AS at least 3 months prior, but no more than 4 years prior to their routine follow-up visit at which they are being recruited for this study.
- Active patients of MSK and participating institutions
You may not qualify if…
- Patients who have been diagnosed with a tumor greater than 2 cm
- Patients with clinically suspicious lymphadenopathy in the neck
- Patients with evidence of gross ETE after a biopsy of the papillary thyroid tumor
Where it is running
- Hartford Healthcare (Data Collection) — Hartford, Connecticut, United States
- Memorial Sloan Kettering Monmouth (Consent and Follow up) — Middletown, New Jersey, United States
- MAIMONIDES MEDICAL CENTER (Data collection only) — Brooklyn, New York, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Lehigh Valley Health Network — Allentown, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.